Ainley, L;
Law, S;
Heptinstall, L;
Rodriguez-Justo, M;
Thomson, K;
Pepper, RJ;
(2020)
Treatment of concurrent minimal change disease and Epstein Barr virus driven post-transplant lymphoproliferative disorder with Rituximab following haematopoietic stem cell transplantation.
Kidney International Reports
10.1016/j.ekir.2020.10.012.
(In press).
Preview |
Text
Law_1-s2.0-S2468024920316508-main.pdf - Accepted Version Download (1MB) | Preview |
| Type: | Article |
|---|---|
| Title: | Treatment of concurrent minimal change disease and Epstein Barr virus driven post-transplant lymphoproliferative disorder with Rituximab following haematopoietic stem cell transplantation |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1016/j.ekir.2020.10.012 |
| Publisher version: | https://doi.org/10.1016/j.ekir.2020.10.012 |
| Language: | English |
| Additional information: | This is an Open Access article published under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) Licence (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
| Keywords: | Nephrotic syndrome, minimal change disease, post-transplant lymphoproliferative disorder, haematopoietic stem cell transplantation, Epstein-Barr virus, Rituximab |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Pathology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10116237 |
Archive Staff Only
 |
View Item |
